Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premedication for IANB in Irreversible Pulpitis
NCT07088042Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2024
- Primary completion
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Limitless Allzyme in irreversible pulpitis, sponsored by Ain Shams University. Started Sep 2024; status: completed.
02
Drugs
Limitless Allzyme
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07088042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07088042.